estimated revenue glp-1 drugs Lilly is now pharma's top company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating The winners and losers from

Schwartz, C

Why To Avoid Compounded Medications Weight management is challenging enough without adding medication uncertainties to the mix

The World Obesity Atlas projects that more than half of the worlds population will be overweight or obese by 2035

Generic Semaglutide Race Heats Up OneSource, a prominent contract development and manufacturing organisation (CDMO), is gearing up to be a key player in the first wave of generic semaglutide launches

Instead, they often contain vitamins or herbs, such as berberine, green tea extract, or Garcinia Cambogia, but there is no scientific evidence that shows these patches work for weight loss

Medications like Wegovy (semaglutide) and Mounjaro (tirzepatide, which is a dual GLP-1/GIP agonist) are administered just once a week using a small, pre-filled injection pen